Medicines Co. (MDCO): MDCO-216 Proof-of-concept Data Coming in 2H, Reit Buy -Jefferies
Tweet Send to a Friend
Jefferies analyst, Biren Amin, expects Medicines Company (NASDAQ: MDCO) to have first proof-of-concept data for MDCO-216 in MILANO-PILOT in the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
